Countdown to a Cure

by Jeannie Wraight As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

Oral Care & Viral Reservoirs

Oral Report Could something as simple as oral care affect viral reservoirs? by Jeannie Wraight Research performed at Case Western found increased levels of HIV in the...

Women & PrEP

LifeGuide It's a Man's World Research on women & PrEP needs to keep pace by Jeannie Wraight   Whereas HIV cure and HIV prevention are two very different...

Orphaned Vaccines

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Eye on the Future

Towards an HIV Cure is an initiative of the International AIDS Society (IAS) formed to help direct and facilitate discussion, research and policy to...

HTVN 702: Vaccine Candidate

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

The True End of AIDS

LifeGuide Trump Card Treatment and prevention are important, but an HIV cure will be the true end of AIDS by Jeannie Wraight Lately, we have been hearing a...

4 CROI Briefs

Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...

Broad Spectrum Antivirals: Part I

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...